Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,031 | -117,177 | -66,375 | -26,563 | -180,664 |
| Depreciation Amortization | 7,174 | 5,470 | 3,298 | 1,658 | 6,546 |
| Income taxes - deferred | -5,226 | -4,192 | -877 | -767 | 3,306 |
| Accounts receivable | N/A | N/A | -232 | N/A | 2,482 |
| Accounts payable and accrued liabilities | 3,095 | -7,593 | -6,354 | -5,923 | 8,002 |
| Other Working Capital | -37,849 | -72,704 | -72,486 | -55,668 | 72,477 |
| Other Operating Activity | 37,113 | 40,868 | 27,530 | 16,394 | 27,223 |
| Operating Cash Flow | $-164,724 | $-155,328 | $-115,496 | $-70,869 | $-60,628 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,235 | -867 | -432 | -12 | -2,929 |
| Investing Cash Flow | $-1,235 | $-867 | $-432 | $-12 | $-2,929 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -31,863 | -31,863 | N/A | N/A | N/A |
| Common Stock Issued | 551,655 | 551,410 | 551,477 | 1,871 | 250,027 |
| Other Financing Activity | -42 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $519,750 | $519,547 | $551,477 | $1,871 | $250,027 |
| Exchange Rate Effect | -694 | 1,087 | -608 | -416 | 1,346 |
| Beginning Cash Position | 526,970 | 526,970 | 526,970 | 526,970 | 339,154 |
| End Cash Position | 880,067 | 891,409 | 961,911 | 457,544 | 526,970 |
| Net Cash Flow | $353,097 | $364,439 | $434,941 | $-69,426 | $187,816 |
| Free Cash Flow | |||||
| Operating Cash Flow | -164,724 | -155,328 | -115,496 | -70,869 | -60,628 |
| Capital Expenditure | -1,235 | -867 | -432 | -12 | -2,929 |
| Free Cash Flow | -165,959 | -156,195 | -115,928 | -70,881 | -63,557 |